Helen Rubinstein | Director, IR |
Barry Greene | Chief Executive Officer |
Kimi Iguchi | Chief Financial Officer |
Jim Doherty | Chief Development Officer |
Chris Benecchi | Chief Business Officer |
Jeff Jonas | Chief Innovation Officer |
Yasmeen Rahimi | Piper Sandler |
Ritu Baral | Cowen |
Salveen Richter | Goldman Sachs |
Paul Matteis | Stifel |
Laura Chico | Wedbush |
Jay Olson | Oppenheimer |
Ami Fadia | Needham & Company |
Sumant Kulkarni | Canaccord Genuity |
Joon Lee | Truist |
Good morning. Welcome to the Sage Therapeutics' Third Quarter 2022 Financial Results Conference Call. Currently, all participants are in a listen-only mode. This call is being webcast live on the Investors and Media section of Sage's website at sagerx.com. This call is the property of Sage Therapeutics and recording, reproduction, or transmission of this call without the expressed written consent of Sage Therapeutics is strictly prohibited.